Browsing Tag
Cardiovascular disease
29 posts
Sanofi strengthens cardiovascular portfolio with Aficamten rights in Greater China
Cytokinetics, Incorporated (NASDAQ: CYTK) saw its shares climb by 4.8% after announcing a landmark agreement with Sanofi (NASDAQ:…
Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment
Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company…
Reflow Medical launches DEEPER CORONARY study in coronary in-stent restenosis
Reflow Medical, Inc. ignites a medical revolution with the first patient enrollments in a pilot study named “DEEPER…
Philips surpasses 1500 cath lab installations in India, enhancing cardiac care
Royal Philips, a global leader in health technology, announced a significant milestone at India Live 2024 in New…
GE HealthCare launches Allia IGS Pulse after FDA 510(k) clearance
GE HealthCare (Nasdaq: GEHC) has stepped into a new era of cardiovascular imaging by announcing the FDA 510(k)…
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their…
Viz.ai partners with UCSF to commercialize AI algorithms for cardiovascular disease detection
Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive…
Merck launches Phase 3 CORALreef program for PCSK9 inhibitor MK-0616
Pharmaceutical giant Merck has announced the initiation of its groundbreaking Phase 3 clinical program, CORALreef, focusing on MK-0616—a…
XyloCor reveals promising 12-month data from Phase 2 Trial of XC001
XyloCor Therapeutics, a clinical-stage biopharmaceutical company focusing on novel gene therapies for cardiovascular diseases, has revealed encouraging 12-month…
FDA approves Cardio Flow Design’s iTFlow for enhanced cardiovascular diagnosis
The US Food and Drug Administration (FDA) has granted approval for iTFlow, a software solution developed by Cardio…